-
Prohibition on Personal Loans. The Company will not extend or maintain credit, arrange for the extension of credit, or renew an extension of credit, in the form of a personal loan to or for any Board member or member of the Company's management.
-
No Repricing of Stock Options. Stock options are always granted with an exercise price that is not less than the fair market value (as defined in the relevant stock option plan) of the Company's common stock on the grant date. The Company will not reprice stock options for any reason (including, without limitation, by canceling an outstanding option and replacing such option with a new option with a lower exercise price).
-
Stock Ownership Goal. The Board believes that significant stock ownership by Board members and members of senior management further aligns their interests with the interests of the Company's stockholders. Accordingly, the Board has established a goal that (a) each non-management Board member own Company shares valued at five times his or her annual retainer fee within five years after joining the Board and (b) within five years after being appointed to his or her position, each member of senior management own Company shares valued at the following multiple of his or her annual base salary:
- 6x for the Executive Chairman of FedEx Corporation (if serving);
- 6x for the President and Chief Executive Officer of FedEx Corporation;
- 3x for the Company’s other executive officers (as defined in Rule 3b-7 under the Securities Exchange Act of 1934);
- 2x for executive vice presidents who are not executive officers, divisional presidents, regional presidents, and enterprise vice presidents; and
- 1x for other senior officers.
For purposes of meeting this goal, unvested restricted stock and restricted stock units
are counted, but unexercised stock options are not. Until the goal is met, the Board member or officer should consider retaining (but is not required to retain) "net profit shares" resulting from the exercise of stock options granted under the Company's equity compensation plans. Net profit shares are the shares remaining after the payment of the option exercise price and taxes owed upon the exercise of options.
-
Policy Against Hedging and Pledging Transactions. Company officers, employees, and Board members are prohibited from, directly or indirectly, purchasing financial instruments or otherwise engaging in transactions that hedge or offset, or are designed to hedge or offset, any decrease in the market value of equity or other securities of the Company or any of its subsidiaries that were granted as compensation to or that are held, directly or indirectly, by the officer, employee, or Board member, including the following financial instruments and transactions:
- Publicly traded (or exchange-traded) options, such as puts, calls, and other derivative securities;
- Short sales, including “sales against the box”;
- Margin accounts and pledges; and
- Hedging or monetization transactions designed to limit the financial risk of ownership, including prepaid variable forward contracts, equity swaps, collars, exchange funds, and other similar transactions.
However, the Lead Independent Director or Vice Chairman of the Board and the Executive Vice President, General Counsel and Secretary may grant an exception to the prohibition against holding Company securities in a margin account or pledging Company securities on a case-by-case basis to any non-management Board member, the Executive Chairman, or the President and Chief Executive Officer, in each case if the requesting person clearly demonstrates the financial capacity to repay the loan without resort to the pledged securities. The President and Chief Executive Officer and the Corporate Vice President – Corporate Governance, Securities, and Tax Law may grant an exception to this prohibition with respect to the Executive Vice President, General Counsel and Secretary, and the Executive Vice President, General Counsel and Secretary may grant case-by-case exceptions in all other instances, in each case if the requesting person clearly demonstrates the financial capacity to repay the loan without resort to the pledged securities. The Executive Vice President, General Counsel and Secretary will inform the Chairman of the Board and the Lead Independent Director of any such exception granted.
-
Confidential Voting. All stockholder proxies, ballots, and voting materials that identify the votes of specific stockholders will be kept confidential and not disclosed to the Company, unless (a) required by law, (b) necessary to assert or defend claims for or against the Company, (c) a stockholder expressly requests disclosure of the stockholder’s vote, (d) a stockholder makes a written comment on a proxy card or ballot or otherwise communicates the stockholder’s vote to management, or (e) there is a (i) proxy contest or (ii) a tender offer or other change-in-control situation.
-
Orientation of New Directors; Continuing Education. The Governance, Safety, and Public Policy Committee will develop and oversee an orientation program for new Board members. The orientation process will include providing new Board members with comprehensive information about the Company's business and financial performance, as well as the policies, procedures, and responsibilities of the Board and its committees. New Board members also will meet with senior management and will have the opportunity to visit Company facilities. In addition, the Company will facilitate and encourage the participation of Board committee chairpersons and other Board members in relevant continuing education programs and activities.
-
Annual Performance Evaluations. The Governance, Safety, and Public Policy Committee will establish appropriate performance criteria and processes for, and implement and oversee, an annual performance evaluation of each Board member, each committee of the Board, and the Board of Directors as a whole. The Governance, Safety, and Public Policy Committee will review the results of each Board committee's evaluation. The chairperson of each Board committee will report the results of his or her committee's evaluation to the Board of Directors and identify opportunities to improve the effectiveness of the committee. The chairperson of the Governance, Safety, and Public Policy Committee also will report to the Board of Directors the results of the full Board and, as appropriate, individual director evaluations.
-
Confidentiality. The proceedings and deliberations of the Board of Directors and
its committees and advisers are confidential. Each Board member should maintain the
confidentiality of all Confidential Information (as defined below) and not, directly or indirectly
(including through agents, representatives, or others acting on behalf of such director), disclose
Confidential Information outside of the Company, except when authorized by the Chairman of
the Board or the Executive Vice President, General Counsel and Secretary or legally required to
disclose such information. Board members should not use Confidential Information acquired in
connection with their service for their personal advantage or for the benefit of persons or entities
outside the Company.
For purposes of these Corporate Governance Guidelines, “Confidential Information”
includes, but is not limited to, all non-public information (whether or not material to the
Company) made available to or obtained by a Board member by reason of his or her position as a
director of the Company. Examples of Confidential Information include, but are not limited to:
(a) financial results and condition, capital expenditures, or projections of such measures; (b)
marketing and sales programs, research and development, intellectual property, and new service
launches; (c) changes in personnel or leadership succession plans or developments in labor
negotiations; (d) information regarding litigation or government investigations involving the
Company or any of its Board members or employees; (e) information regarding data breaches,
cyberattacks, cyber intrusions, or other disruptions to the Company’s technology infrastructure;
(f) potential business transactions, such as mergers, acquisitions, divestitures, or joint ventures,
or developments regarding integrations of acquired entities; (g) changes in dividend policies,
stock repurchase authorizations and transactions, and capital market transactions; (h) information
regarding other companies or persons with whom the Company may conduct business, such as
information about the Company’s customers and suppliers and contracts with such parties; (i)
minutes, reports, materials, and other documents of the Board and its committees; the fact of, or
contents of, meetings, presentations, and discussions of and to the Board and its committees (and
between any Board members) and/or their advisers (including the views of any individual
director or officer); and the identity, circumstances, and fact of retention of any such advisers; (j)
information regarding the strategy, business, operations, projections, forecasts, prospects, and
plans of the Company or the competitive conditions it faces; and (k) information that might be of
use to competitors or other persons or entities with interests adverse to, or harmful to, the
Company or its customers, suppliers, or other stakeholders if disclosed.
If a Board member has a question regarding how to treat any information pursuant to
these Corporate Governance Guidelines, in advance of any disclosure of such information the
question should be raised with the Executive Vice President, General Counsel and Secretary, and
a substantive response will be provided to the inquiring director. If disclosure of information by a
director occurs in violation or potentially in violation of these Corporate Governance Guidelines,
the content and circumstances of such disclosure should be reported immediately to the
Executive Vice President, General Counsel and Secretary.
Directors are subject to these obligations during and after their service on the Board
-
Interaction with Investors, Press, Customers, and Other Stakeholders The Board
believes that it is Company management’s responsibility to speak for the Company. If public
comments from the Board are appropriate, they will, in most circumstances, come from the
Chairman of the Board. Non-management Board members should only meet or otherwise
communicate with investors and other outside constituencies regarding the Company following
the approval of the Chairman of the Board or the Executive Vice President, General Counsel and
Secretary.
-
Board Member Attendance at Annual Meetings. Board members are expected to attend annual meetings of the Company's stockholders.
-
Policy Statement on Poison Pills. The Company does not currently have a shareholder rights plan, or "poison pill." The Company's bylaws require that the Board obtain stockholder approval prior to adopting a poison pill unless the Board, including a majority of the independent members of the Board, in the exercise of its fiduciary responsibilities, determines that, under the circumstances then existing, it would be in the best interests of the Company and its stockholders to adopt a poison pill without prior stockholder approval. The bylaws provide that if a poison pill is adopted by the Board without prior stockholder approval, the poison pill must provide that it will expire within one year of adoption unless ratified by stockholders.